Skip to content

Computer-assisted deep learning multimodal MRI in predicting Postoperative cognitive dysfunction in patients with Cerebral Small Vessel Disease: a prospective cohort study

Computer-assisted deep learning multimodal MRI in predicting Postoperative cognitive dysfunction in patients with Cerebral Small Vessel Disease: a prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035681
Enrollment
Unknown
Registered
2020-08-16
Start date
2020-12-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative Cognitive Dysfunction

Interventions

patient without CSVD: N/A
patient with CSVD(Evaluating group):N/A

Sponsors

Renji Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. aged 65 to 85 years; 2. To undergo elective surgery of the non-heart and non-central nervous system; 3. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Persons with mental illness; 2. Had other diseases that can lead to dementia, such as Alzheimer's disease, Lewy body dementia, prefrontal dementia, progressive supravuclear palsy, Parkinson's disease, Creutzfeldt-Jakob disease, Huntington's disease, alcohol and drug dependence, neurosyphilis, and systemic lupus erythematosus; Or preoperative MRI showed more than grade II hippocampal and temporal lobe atrophy, suggesting the possibility of Alzheimer's disease; 3. Had other brain diseases (such as stroke, multiple sclerosis, central nervous system infection with sequelae, etc.); 4. Preoperative MRI indicated the presence of diseases that impair the function of the central nervous system, such as stroke and brain tumor; 5. Unable to complete THE MMSE and MoCA scales due to other reasons (such as hearing impairment or visual impairment); 6. Patients who have MRI contraindications or cannot tolerate MRI imaging; 7. Malignant tumor stage 3 or 4 patients, and pancreatic cancer, gallbladder cancer, cholangiocarcinoma and other tumor patients with high degree of malignancy and poor prognosis.

Design outcomes

Primary

MeasureTime frame
incidence of POCD;incidence of CSVD;

Secondary

MeasureTime frame
incidence of delirium;

Countries

China

Contacts

Public ContactPeiying Li

Department of Anesthesiology, Renji Hospital

peiyingli.md@gmail.com+86 15800616866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026